ILHAM HIDAYATTULAH

“Distributors with existing IPAK licenses will need to show compliance to CDAKB upon renewal. Manufacturers should confirm with their distributors that they are in compliance by the time their IPAK license is set to expire.”

Ilham Hidayattulah
Principal Consultant
Asia Actual Indonesia

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sign Up For Our Newsletter to Stay Informed

Sign Up

Good Distribution Practice Requirements (CDAKB) in Indonesia

Published on: October 28th, 2022

New Requirements Put in Place in 2020

In 2014, the Indonesian Ministry of Health introduced the Good Method of Distribution of Medical Devices (or CDAKB) in order to enforce good distribution practice requirements in the country. The CDAKB is a series of guidelines put in place to standardize quality control across the Indonesian medical device market. The regulation has had a long period of implementation, only becoming mandatory in 2020, six years after its introduction. 

CDAKB was put in place to regulate quality control across medical devices distributed in Indonesian markets. It affects all major aspects of distribution, including handling of products and record keeping. The CDAKB makes it so that in the event of a product recall there is a clear pipeline of access to the distributors/manufacturer in order to ensure complete user safety. This brings local alignment with similar distributor requirements in the region like GDPMDS in Singapore. If you are looking for more specific information on CDAKB compliance please contact us here. 

The following are requirements of CDAKB and are utilized to promote good distribution practice in Indonesia: 

  1. Quality management system
  2. Resource management
  3. Building and facilities 
  4. Storage and inventory handling 
  5. Product traceability  
  6. Complaint handling 
  7. Field safety corrective action 
  8. Return system 
  9. Destruction system 
  10. Illegal and unqualified medical devices recording 
  11. Internal audit 
  12. Management review 
  13. 3rd party / Outsourcing activity 

CDAKB Compliance Required for New and Renewing IPAK Licenses 

There is no set implementation date for the CDAKB guidelines, however, a certificate of CDAKB compliance is now required to receive an IPAK certificate, the Indonesian medical device distribution license which retains its validity for five years. In order to renew their IPAK certificate, or recieve a new one, Indonesian distributors must be CDAKB compliant, making it imperative for medical device distributors in the region to follow the guidelines set forth by the Ministry of Health. More information on Indonesia License Holding and Indonesia Medical Device Registration can be found on the Asia Actual website.  

Requirements are similar to those found in ISO 13485, whose specifications can be found here. Manufacturers will want to check with their distributors to ensure they meet the qualifications set forth in this notice.  

The CDAKB Requirements for distributors are detailed below. Indonesian distributors looking to be IPAK certified must submit evidence of the following:  

  1. Company Data, including valid IPAK (if renewing), medical device approval, and more.  
  2. Technical person of responsibility on staff.  
  3. Management representative on staff for licensing procedures, and more.  
  4. Distribution quality control procedures.  
  5. Hygiene, pest control, safety quality procedures.  
  6. Human resources procedures, including employee recruitment and training.  
  7. Marketing, including customer satisfaction, complaint and quality procedures.  
  8. Purchasing procedures, including supplier selection and evaluation.  
  9. Storage capabilities.  
  10. Maintenance and repair procedures.  

Come Grow with Us 

Asia Actual has an office in Indonesia staffed by experienced, bilingual regulatory and commercial professionals to address any questions or provide support. Please contact us to explore if this new program is appropriate for your devices. 

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services. 

Blog Posts

China’s NMPA Updates Medical Device Classification Catalogue

China’s National Medical Products Administration (NMPA) maintains a list of all medical device categories called the Medical Device Classification Catalogue. NMPA published a notice on August 17, 2023, that they had released amendments to the Medical Device Classification Catalogue. It’s important for manufacturers to understand these changes as they can significantly impact the cost and time to register medical devices.
Read more

Thai FDA Drafting New Guidance for SaMD and AI Device Registration

Thai FDA is drafting new guidelines for AI Regulation. The novel characteristics of artificial intelligence (AI) software cause issues with the medical device registration process in most countries. The Thai Food and Drug Administration (Thai FDA) is working to address this important issue, most recently by hosting a meeting with interested parties on July, 2023, which Asia Actual Thailand employees were invited to attend.
Read more

China NMPA Adds 47 Products to Clinical Trial Exemption List

China’s National Medical Products Administration (NMPA) updated its clinical trial exemption list, adding 47 products. The NMPA updates this list every two to three years, with the last amendment in 2021. This brings the total number of clinical trial exempted product categories in China to 1,025.
Read more